<span item_type="fundamental" item_id="f6896660431c287fefa8329f8c80adae" counter_id="ST/US/ALCYU" env="prod"></span><span item_type="announcement" item_id="554166964331548801" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD -0.05.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of June 30, 2025, as it is still in the process of identifying a potential business combination target.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Loss</strong>: For the three months ended June 30, 2025, the company reported a net loss of $220,257, compared to a net income of $1,313,741 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li><li><strong>Operating Costs</strong>: Operating and formation costs were $321,051 for the three months ended June 30, 2025, compared to $279,191 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow</strong>: Net cash used in operating activities was - $619,969 for the six months ended June 30, 2025, compared to - $267,346 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li><li><strong>Financing Activities</strong>: Net cash provided by financing activities was $600,000 for the six months ended June 30, 2025, due to proceeds from a related party promissory note.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Gain on Investments</strong>: The company reported a gain on investments held in the Trust Account of $126,034 for the three months ended June 30, 2025, compared to $1,591,454 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to consummate a business combination by the extended date of September 9, 2025, following shareholder approval to extend the deadline from November 9, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li><li><strong>Non-Core Business</strong>: The company has not engaged in any operations or generated revenues, focusing solely on identifying a business combination target.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1901336/000141057825001903/alcy-20250630x10q.htm"></span></li></ul>

ALCYU

Alchemy Investments Acquisition Corp 1 - Unit | 10-Q: FY2025 Q2 EPS: USD -0.05